United States Biotechnology & Medical Research

Cue Biopharma Inc (CUE)

Track

The most recent insider trading activity at Cue Biopharma Inc occurred on December 30, 2025, involving multiple purchase transactions by Pasha Sarraf. Prior to this, a proposed sale was filed on December 29, 2025. No insider trading activity has been recorded within the last three months.
Ticker: CUE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cue Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 30 Dec 2025
Value US$3,986,671.78 | Price 489.62 | Shares 71,297 (-2.9%)
Buy 30 Dec 2025
Value US$2,697,469.27 | Price 471.19 | Shares 66,462 (-40.9%)
Buy 30 Dec 2025
Value US$27,596.98 | Price 0.32 | Shares 86,947 (+106.8%)
Buy 30 Dec 2025
Value US$23,167.54 | Price 0.30 | Shares 77,148 (+1824.3%)
Buy 30 Dec 2025
Value US$1,308.45 | Price 0.31 | Shares 4,229 (+inf%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
71,297 -2.9%
489.62
US$3,986,672 		71,297 -2.9% 489.62 US$3,986,672
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
66,462 -40.9%
471.19
US$2,697,469 		66,462 -40.9% 471.19 US$2,697,469
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
23,479 -8.4%
85.78
US$1,786,666 		23,479 -8.4% 85.78 US$1,786,666
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
77,148 +1824.3%
0.30
US$23,168 		77,148 +1824.3% 0.30 US$23,168
2026-01-02 2025-12-30 B Purchase
2.4
Sarraf Pasha
Non-Executive Director
4,229 +inf%
0.31
US$1,308 		4,229 +inf% 0.31 US$1,308
2025-12-29 2025-12-29 PrS Proposed sale
MATTEO GIACOMO LEVISETTI

Officer

Officer
7,230
0.26
US$1,907 		7,230 0.26 US$1,907
2024-12-18 2024-12-16 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +22.3%
1.03
US$30,900 		30,000 +22.3% 1.03 US$30,900
2023-08-29 2023-08-25 B Purchase
1.4
Suri Anish

PRESIDENT AND CSO

Officer
4,000 +3.0%
2.76
US$11,040 		4,000 +3.0% 2.76 US$11,040
2023-08-16 2023-08-14 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
3,000 +2.3%
2.86
US$8,580 		3,000 +2.3% 2.86 US$8,580
2023-03-27 2023-03-23 S Sale
0.6
Kiener Peter A
Non-Executive Director
9,325 -96.3%
3.28
US$30,586 		9,325 -96.3% 3.28 US$30,586
2022-05-31 2022-05-27 B Purchase
0.6
Morich Frank
Non-Executive Director
28,000 +inf%
3.75
US$105,000 		28,000 +inf% 3.75 US$105,000
2022-05-25 2022-05-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
55,000 +6.2%
3.34
US$183,700 		55,000 +6.2% 3.34 US$183,700
2022-05-25 2022-05-23 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
150,000 +20.4%
3.52
US$528,000 		150,000 +20.4% 3.52 US$528,000
2022-04-04 2022-03-31 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
735,000 +inf%
4.76
US$3,498,600 		735,000 +inf% 4.76 US$3,498,600
2021-11-17 2021-11-16 PlS Planned sale
0.6
Kiener Peter A
Non-Executive Director
1,361 -100.0%
18.02
US$24,525 		1,361 -100.0% 18.02 US$24,525
2021-11-17 2021-11-15 PlS Planned sale
0.6
Kiener Peter A
Non-Executive Director
18,815 -100.0%
17.92
US$337,165 		18,815 -100.0% 17.92 US$337,165
2021-11-17 2021-11-15 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
8,000 -7.8%
18.05
US$144,400 		8,000 -7.8% 18.05 US$144,400
2021-11-15 2021-11-11 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
20,000 -17.5%
15.07
US$301,354 		20,000 -17.5% 15.07 US$301,354
2021-10-05 2021-10-01 PlS Planned sale
Millar Kerri-Ann

CHIEF FINANCIAL OFFICER

Officer
1,251 -10.7%
14.21
US$17,783 		1,251 -10.7% 14.21 US$17,783
2021-09-27 2021-09-24 B Purchase
2.5
PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER

Executive Director
3,400 +6.5%
14.72
US$50,051 		3,400 +6.5% 14.72 US$50,051
2021-09-27 2021-09-23 PlS Planned sale
1.4
Suri Anish

PRESIDENT AND CSO

Officer
20,000 -21.1%
15.23
US$304,646 		20,000 -21.1% 15.23 US$304,646
2021-03-17 2021-03-16 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
439 -18.0%
15.09
US$6,626 		439 -18.0% 15.09 US$6,626
2021-03-17 2021-03-15 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
13,000 -86.7%
15.10
US$196,269 		13,000 -86.7% 15.10 US$196,269
2021-02-18 2021-02-17 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
4,274 -68.1%
15.06
US$64,345 		4,274 -68.1% 15.06 US$64,345
2021-02-18 2021-02-16 PlS Planned sale
0.8
Pienta Kenneth

Chief Medical Officer

Officer
16,000 -88.9%
15.15
US$242,422 		16,000 -88.9% 15.15 US$242,422
2021-01-22 2021-01-20 B Purchase
0.8
Pienta Kenneth

Chief Medical Officer

Officer
2,720 +136.0%
15.07
US$40,980 		2,720 +136.0% 15.07 US$40,980
2020-11-25 2020-11-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
6,548 +4.1%
12.64
US$82,776 		6,548 +4.1% 12.64 US$82,776
2020-10-01 2020-09-30 B Purchase
1.0
Gray Cameron
Non-Executive Director
5,000 +0.7%
15.30
US$76,500 		5,000 +0.7% 15.30 US$76,500
2020-10-01 2020-09-29 B Purchase
1.0
Gray Cameron
Non-Executive Director
5,000 +0.7%
15.00
US$75,000 		5,000 +0.7% 15.00 US$75,000
2020-08-07 2020-08-05 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
13,274 -43.7%
20.00
US$265,480 		13,274 -43.7% 20.00 US$265,480
2020-08-07 2020-08-05 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
800 -2.3%
20.01
US$16,008 		800 -2.3% 20.01 US$16,008
2020-08-05 2020-08-04 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
400 -1.1%
20.14
US$8,056 		400 -1.1% 20.14 US$8,056
2020-08-05 2020-08-04 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
201 -1.2%
20.05
US$4,030 		201 -1.2% 20.05 US$4,030
2020-08-05 2020-08-03 PlS Planned sale
1.4
Suri Anish

President and CSO

Officer
5,800 -14.4%
20.01
US$116,058 		5,800 -14.4% 20.01 US$116,058
2020-08-05 2020-08-03 PlS Planned sale
2.0
Sandercock Colin

SVP, General Counsel and Sec

Officer
6,425 -27.3%
20.00
US$128,500 		6,425 -27.3% 20.00 US$128,500
2020-06-25 2020-06-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
2,953 +1.9%
25.24
US$74,534 		2,953 +1.9% 25.24 US$74,534
2020-06-25 2020-06-24 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director
4,547 +3.0%
24.64
US$112,038 		4,547 +3.0% 24.64 US$112,038
2019-12-31 2019-12-31 S Sale MARLETT CHRISTOPHER A Non-Executive Director
9,000 -100.0%
15.71
US$141,390 		9,000 -100.0% 15.71 US$141,390
2019-12-31 2019-12-31 S Sale MARLETT CHRISTOPHER A Non-Executive Director
6,700 -0.9%
15.77
US$105,659 		6,700 -0.9% 15.77 US$105,659
2019-12-31 2019-12-27 S Sale MARLETT CHRISTOPHER A Non-Executive Director
9,000 -1.1%
17.24
US$155,160 		9,000 -1.1% 17.24 US$155,160
2019-12-27 2019-12-26 S Sale MARLETT CHRISTOPHER A Non-Executive Director
19,647 -2.4%
17.53
US$344,412 		19,647 -2.4% 17.53 US$344,412
2019-12-27 2019-12-23 S Sale MARLETT CHRISTOPHER A Non-Executive Director
17,000 -2.1%
16.82
US$285,940 		17,000 -2.1% 16.82 US$285,940
2019-12-19 2019-12-19 S Sale MARLETT CHRISTOPHER A Non-Executive Director
4,000 -0.5%
17.00
US$68,000 		4,000 -0.5% 17.00 US$68,000
2019-12-19 2019-12-17 S Sale MARLETT CHRISTOPHER A Non-Executive Director
20,732 -2.5%
15.73
US$326,114 		20,732 -2.5% 15.73 US$326,114
2019-06-25 2019-06-21 B Purchase
2.5
PASSERI DANIEL R

CEO and President

Executive Director
1,377 +2.7%
7.26
US$9,997 		1,377 +2.7% 7.26 US$9,997
2019-06-10 2019-06-10 B Purchase
2.0
Sandercock Colin

SVP, General Counsel and Sec
14,938 +746.9%
7.93
US$118,458 		14,938 +746.9% 7.93 US$118,458
2019-06-10 2019-06-06 B Purchase
2.0
Sandercock Colin

SVP, General Counsel and Sec
2,000 +inf%
7.10
US$14,200 		2,000 +inf% 7.10 US$14,200
2019-06-07 2019-06-06 B Purchase
2.5
PASSERI DANIEL R

CEO and President

Executive Director
3,000 +6.3%
6.90
US$20,700 		3,000 +6.3% 6.90 US$20,700
2019-01-02 2018-12-31 B Purchase
3.9
MARLETT CHRISTOPHER A
Non-Executive Director
18,521 +26.1%
4.64
US$85,937 		18,521 +26.1% 4.64 US$85,937
2019-01-02 2018-12-28 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
7,000 +14.0%
4.62
US$32,340 		7,000 +14.0% 4.62 US$32,340
2018-12-28 2018-12-27 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
20,000 +66.7%
4.77
US$95,400 		20,000 +66.7% 4.77 US$95,400
2018-12-27 2018-12-26 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
19,647 +38.2%
4.29
US$84,286 		19,647 +38.2% 4.29 US$84,286
2019-01-04 2018-12-24 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
10,000 +50.0%
4.81
US$48,100 		10,000 +50.0% 4.81 US$48,100
2018-12-26 2018-12-21 B Purchase Suri Anish

Chief Scientific Officer

Officer
2,000 +inf%
4.37
US$8,740 		2,000 +inf% 4.37 US$8,740
2018-12-26 2018-12-21 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
17,200 +50.2%
4.53
US$77,916 		17,200 +50.2% 4.53 US$77,916
2018-12-26 2018-12-21 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
10,000 +100.0%
4.49
US$44,900 		10,000 +100.0% 4.49 US$44,900
2018-12-21 2018-12-20 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
9,438 +38.1%
4.74
US$44,736 		9,438 +38.1% 4.74 US$44,736
2018-12-20 2018-12-19 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
400 +1.6%
5.00
US$2,000 		400 +1.6% 5.00 US$2,000
2018-12-19 2018-12-18 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
3,664 +17.7%
5.20
US$19,053 		3,664 +17.7% 5.20 US$19,053
2018-12-18 2018-12-17 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
10,000 +inf%
5.48
US$54,800 		10,000 +inf% 5.48 US$54,800
2018-12-17 2018-12-13 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
10,000 +93.2%
5.06
US$50,600 		10,000 +93.2% 5.06 US$50,600
2018-12-13 2018-12-12 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
3,189 +42.3%
5.07
US$16,168 		3,189 +42.3% 5.07 US$16,168
2018-12-13 2018-12-12 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
9,000 +inf%
5.09
US$45,810 		9,000 +inf% 5.09 US$45,810
2018-12-12 2018-12-11 B Purchase MARLETT CHRISTOPHER A Non-Executive Director
7,543 +inf%
4.86
US$36,659 		7,543 +inf% 4.86 US$36,659
2018-08-29 2018-08-29 B Purchase Millar Kerri-Ann

VP-Finance

Officer
1,000 +inf%
8.48
US$8,480 		1,000 +inf% 8.48 US$8,480
2018-08-20 2018-08-16 B Purchase PASSERI DANIEL R

CEO and President

Executive Director
6,000 +14.4%
8.09
US$48,510 		6,000 +14.4% 8.09 US$48,510
2018-06-29 2018-06-29 B Purchase PASSERI DANIEL R

CEO and President

Executive Director
1,600 +4.0%
11.97
US$19,152 		1,600 +4.0% 11.97 US$19,152
2018-01-19 2017-12-27 B Purchase Pienta Kenneth

Chief Medical Officer

Officer
2,000 +inf%
7.50
US$15,000 		2,000 +inf% 7.50 US$15,000
Explore more

More insider trading research around Cue Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America